2017
DOI: 10.1016/j.dadm.2016.12.014
|View full text |Cite
|
Sign up to set email alerts
|

Retinal thickness in Alzheimer's disease: A systematic review and meta‐analysis

Abstract: IntroductionRetinal characteristics are increasingly recognized as biomarkers for neurodegenerative diseases. Retinal thickness measured by optical coherence tomography may reflect the presence of Alzheimer's disease (AD). We performed a meta-analysis on retinal thickness in AD and mild cognitive impairment (MCI) patients and healthy controls (HCs).MethodsWe selected 25 studies with measurements of retinal thickness including 887 AD patients, 216 MCI patients, and 864 HCs that measured retinal thickness. Outco… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

8
119
3
4

Year Published

2018
2018
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 166 publications
(145 citation statements)
references
References 50 publications
8
119
3
4
Order By: Relevance
“…These results provide an in vivo validation for that which was previously observed ex vivo by Perez et al 44 In future studies, the inner and outer retina could be subdivided further to quantify individual layer thickness. Since RNFL thinning occurs in AD patients, 28,29 it may also be interesting to quantify the RNFL thickness alone in this mouse model. However, quantifying the RNFL thickness in mice using OCT is difficult, as the peripapillary thickness of the healthy RNFL is only approximately 20 µm, 74 and is interrupted by blood vessels and ganglion cells.…”
Section: Cortical Amyloid Beta Plaque Loadmentioning
confidence: 99%
See 1 more Smart Citation
“…These results provide an in vivo validation for that which was previously observed ex vivo by Perez et al 44 In future studies, the inner and outer retina could be subdivided further to quantify individual layer thickness. Since RNFL thinning occurs in AD patients, 28,29 it may also be interesting to quantify the RNFL thickness alone in this mouse model. However, quantifying the RNFL thickness in mice using OCT is difficult, as the peripapillary thickness of the healthy RNFL is only approximately 20 µm, 74 and is interrupted by blood vessels and ganglion cells.…”
Section: Cortical Amyloid Beta Plaque Loadmentioning
confidence: 99%
“…26,27 Retinal layer thinning, particularly in the retinal nerve fiber layer (RNFL), is also present in the retina of AD patients. 28,29 However looking forward to a marker for diagnosis, RNFL thinning is not specific to AD and it is not only associated with other diseases such as glaucoma 30 and Parkinson's disease, 31 but also more generally with increasing age. 32 With many contradictory observations, it is clear that there is still a great deal of research to be performed in order to fully understand the effects of AD on the retina.…”
Section: Introductionmentioning
confidence: 99%
“…Истончение комплекса ГКС и СНВС описано при болезни Альцгеймера [24] и болезни Паркинсона [25]. По данным метаанализа, включавшего 25 исследований, 887 пациентов, при болезни Альцгеймера отмечается общее снижение толщины СНВС, максимально выраженное в верхнем и нижнем квадрантах [26]. Установлено также снижение толщины сетчатки во всех отделах макулярной зоны с максимальным истончением в периферических отделах, относящихся к магноцеллюлярной системе [26].…”
Section: Discussionunclassified
“…По данным метаанализа, включавшего 25 исследований, 887 пациентов, при болезни Альцгеймера отмечается общее снижение толщины СНВС, максимально выраженное в верхнем и нижнем квадрантах [26]. Установлено также снижение толщины сетчатки во всех отделах макулярной зоны с максимальным истончением в периферических отделах, относящихся к магноцеллюлярной системе [26]. Подобный паттерн атрофии клеток отмечают при глаукоме [27,28], сходство в патогенезе данных заболеваний подтверждают и другие исследования [29,30].…”
Section: Discussionunclassified
“…Other biomarkers of AD were studied based on the hypothesis that AD is a vascular disorder [10]. Alternative biomarkers were also put forward, like the thinning of the retinal nerve fibre layer (RNFL) in the eyes of AD patients [11,12]. Here, a particularly confounding factor is the fact that RNFL thinning is not exclusive to AD [13].…”
Section: Introductionmentioning
confidence: 99%